HighTower Advisors’s Thermo Fisher Scientific TMO Stock Holding History

HighTower Advisors’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-100	Closed	-$973	–	3978
2024 Q2	$973	Sell	100 -300	-75%	-$172K	﹤0.01%	3564
2024 Q1	$460	Hold	400	–	–	﹤0.01%	3549
2023 Q4	$3.28K	Buy	400 +389	+3,536%	+$188K	﹤0.01%	3488
2023 Q3	$9.57K	Hold	11	–	–	﹤0.01%	3388
2023 Q2	$15.2K	Sell	11 -1,489	-99%	-$804K	﹤0.01%	3271
2023 Q1	$19.1K	Buy	1,500 +1,485	+9,900%	+$837K	﹤0.01%	3150
2022 Q4	$28.3K	Buy	15 +14	+1,400%	+$7.42K	﹤0.01%	3093
2022 Q3	$4K	Buy	+1	New	+$560	﹤0.01%	3067
2022 Q1	–	Sell	-1	Closed	-$39K	–	3682
2021 Q4	$39K	Buy	+1	New	+$624	﹤0.01%	3050
2020 Q2	–	Sell	-100	Closed	-$4K	–	2538
2020 Q1	$4K	Hold	100	–	–	﹤0.01%	2153
2019 Q4	$1K	Hold	100	–	–	﹤0.01%	2269
2019 Q3	$1K	Buy	+100	New	+$28.6K	﹤0.01%	2397
2014 Q2	–	Sell	-100	Closed	-$1K	–	1711
2014 Q1	$1K	Buy	+100	New	+$11.9K	﹤0.01%	1586

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

HighTower Advisors's TMO Position: Q1 2026 in Review

HighTower Advisors reduced its Thermo Fisher Scientific (TMO) stake by 0.03% in Q1 2026, selling an estimated $20.6K and leaving 145,001 shares worth $71.3M. The position accounts for 0.08% of the portfolio, ranked #263.

HighTower Advisors first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $113M in Q3 2024. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

HighTower Advisors held 145,001 shares of Thermo Fisher Scientific worth $71.3M as of Q1 2026.
HighTower Advisors sold 38 Thermo Fisher Scientific shares in Q1 2026, an estimated $20.6K.
Thermo Fisher Scientific made up 0.08% of HighTower Advisors's portfolio in Q1 2026, its #263 holding.
HighTower Advisors first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
HighTower Advisors's Thermo Fisher Scientific position peaked at $113M in Q3 2024.
2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.